CAS: 189059-71-0 - (1-{[(3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]acetyl}piperidin-4-yl)acetic acid

Formule : C₃₁H₃₉ClN₂O₈

InChI : InChI=1S/C31H39ClN2O8/c1-31(2,18-35)17-34-23-9-8-20(32)15-22(23)28(21-6-5-7-24(40-3)29(21)41-4)42-25(30(34)39)16-26(36)33-12-10-19(11-13-33)14-27(37)38/h5-9,15,19,25,28,35H,10-14,16-18H2,1-4H3,(H,37,38)/t25-,28-/m1/s1

Code InChI : InChIKey=HDGUKVZPMPJBFK-LEAFIULHSA-N

SMILES : O=C(O)CC1CCN(C(=O)CC2OC(C=3C=CC=C(OC)C3OC)C4=CC(Cl)=CC=C4N(C2=O)CC(C)(C)CO)CC1

Synonymes :

• 1-[2-[(3R,5S)-7-Chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-4-piperidineacetic acid
• 4-Piperidineacetic acid, 1-[[(3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-
• 4-Piperidineacetic acid, 1-[[7-chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-, (3R-trans)-
• 4-piperidineacetic acid, 1-[2-[(3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-
• Lapaquistat
• T 91485

Lapaquistat

CAS : 189059-71-0

Lapaquistat is a drug that inhibits the activity of protein kinase C-ε, which plays a …

• Formule : C₃₁H₃₉ClN₂O₈
• Degré de pureté : Min. 95%
• Masse moléculaire : 603.1 g/mol

Lapaquistat

CAS : 189059-71-0

Lapaquistat: active TAK-475 metabolite; reduces cholesterol synthesis and statin myotoxicity.

• Formule : C₃₁H₃₉ClN₂O₈
• Degré de pureté : 98%
• Couleur et forme : Solid
• Masse moléculaire : 603.1